Note Mass General case. by Peter Gosselin, ProPublica, Dec. 28 Tom Steckel hunched over a laptop in the overheated basement of the state Capitol building in Pierre, South Dakota, early last week, trying to figure out how a newly awarded benefit claims contract will make it easier for him do his job.Steckel is South Dakota’s … Continue reading ProPublica: If You’re Over 50, Chances Are the Decision to Leave a Job Won’t be Yours
Thanks to Fred Hapgood and his thorough list of lectures. As always, double check times, locations and access. Noon. "Can Machine-Learning Improve Cardiovascular Risk Prediction using Routine Clinical Data?" Stephen F. Weng. Countway Library 424. Details, Registration. This event will be streamed. 4p. "The Role of Sex and Gender in Metabolic Health and Function."Deborah Clegg. … Continue reading 12/18/2018: Health events in Boston today
This morning's Globe quotes Donald Berwick, MD, on the potential impact of last week's court ruling declaring the ACA unconstitutional in Massachusetts. Readers not yet eligible for Medicare take note. ...Massachusetts relies on billions of dollars in federal funding every year to provide coverage to lower-income residents, and the state’s health care system is deeply … Continue reading Globe: Will court ruling on the #AffordableCareAct impact #Massachusetts?
Liz Kowalczyk reports on a BMJ study out of Boston Children's Hospital Patient “rounds’’ — the crucial daily meetings when doctors and other caregivers determine treatment — often occur in hospital hallways and remote conference rooms. But a study led by Boston researchers concluded that it’s far safer to do rounds right at the bedside, … Continue reading Hello. I’m here: Globe reports on benefits of keeping #hospitalized #patients in the loop during #rounds.
11/19 update: Audio from the event. Activist docs argue that people are dying for lack of access to insulin. Tomorrow -- Friday -- the Right Care Alliance will take that complaint to the Sanofi offices in Cambridge. More here from STAT, including a company statement noting that it provides free medications for some low-income, uninsured … Continue reading In Boston, docs to use direct action to #protest the #price of #insulin
From HBR, which has a three story pay-wall: Many factors make an organization prone to sexual harassment: a hierarchicalstructure, a male-dominated environment, and a climate that tolerates transgressions — particularly when they are committed by those with power. Medicinehas all three of these elements. And academic medicine, compared to other scientific fields, has the highest incidence of gender and … Continue reading Harvard Business Review on sexual harassment in health care
Live streamed Harvard event on adolescent mental health beyond the clinic. The Child Mental Health Forum talks run through May. 10 AM- 11:15 a.m. at the Judge Baker Children’s Center 53 Parker Hill Avenue, Boston, Limited free parking available November 7th, 2018 “Addressing Adolescent Mental Health Beyond the Clinic: Lessons from the Global South” Vikram Patel, … Continue reading 11/7 Live streamed Harvard event: “Addressing Adolescent Mental Health Beyond the Clinic: Lessons from the Global South”
That's what Rudolph Tanzi, a prominent Alzheimer's researcher at MGH says about the work of Robert Moir, a member of his team. A story in STAT last week -- which ran in today's Globe - chronicles Moir's struggle to get funding for a theory that Alzheimer’s disease is a triggered by microbes in the brain. "If true, the … Continue reading STAT: :Neuroinflammation is where we’re going to find [Alzheimer’s] drugs.”
defaultEmmarie Huetteman and Sydney Lupkin, Kaiser Health News Before the midterm elections heated up, dozens of drugmakers had already poured about $12 million into the war chests of hundreds of members of Congress. Since the beginning of last year, 34 lawmakers have each received more than $100,000 from pharmaceutical companies. Two of those — Reps. … Continue reading KHN: Drugmakers Funnel Millions To Lawmakers; A Few Dozen Get $100,000-Plus
From The Globe and Mail: Canadian governments should not pay for a $250,000-a-year cystic fibrosis medication because it is not clear the drug actually improves patients’ health, according to a fresh review that has devastated some with the potentially fatal lung disease.... In a report released on Thursday, the CADTH’s expert panel said its review … Continue reading Is the US setting the bar too low for new CF drug? Canada says it’s not worth it